We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Taysha Gene Therapies Inc | NASDAQ:TSHA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.09 | 3.91% | 2.39 | 890,189 | 05:00:04 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.80 | 2.57 | 2.45 | 2.295 | 2.35 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 15.45M | -111.57M | -0.5967 | -4.01 | 446.83M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 23:00:01 | 30 | 2.3513 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/9/2023 | 21:52 | DJN | Taysha Gene Therapies to End Development of TSHA-120 After FDA Feedback |
| 24/8/2023 | 13:52 | DJN | Taysha Gets FDA Fast-Track for Rett Syndrome Treatment |
Taysha Gene Therapies (TSHA) Share Charts1 Year Taysha Gene Therapies Chart |
|
1 Month Taysha Gene Therapies Chart |
Intraday Taysha Gene Therapies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
